Press release
NICOX discusses New Glaucoma Treatment at SMi’s 3rd Ophthalmic Drugs Conference
Gavin Spencer who is Executive Vice President & Chief Business Officer, will be presenting at the third annual Ophthalmic Drugs Conference, where he will discuss the development of NCX 470. He will also focus on the role of nitric acid in control intraocular pressure and future generation compounds from the NICOX platform.
On Day Two of the conference, under the same discussion point on New Developments in Ophthalmic Clinical Trials and Drug Development, Parisa Zamiri, Global Head of Clinical Development in Ophthalmology at Novartis Pharmaceutical will discuss the transformation of future eye care and Virginia Calder, Reader in Ocular Immunology from UCL Institute of Ophthalmology highlights the use of experimental models to identify potential anti-inflammatory drugs in allergic conjunctivitis and uveitis.
Other high-profile speakers presenting include:
Aniz Girach, Chief Medical Officer, ProQR Therapeutics
Daniel Chung, Global Medical Strategy Lead-Ophthalmology, Spark Therapeutics
Michael Ehrlich, Senior Clinical Program Lead - Retinopathies, Boehringer Ingelheim
Peter Morgan-Warren, Medical Assessor, MHRA
Further details about the event can be found on the website www.ophthalmicdrugs.com/pr4
Sponsored by:
EXPERIMENTICA | ProMed Pharma
Contacts:
Sponsorship, exhibition and branding packages: Alia Malick +44 (0)20 7827 6168 / amalick@smi-online.co.uk
Delegate enquiries: contact Alex Vidic on: +44 (0) 20 3866 0221 / avidic@smi-online.co.uk
Media enquiries contact Neill Howard +44 (0) 207 827 6164 / nhoward@smi-online.co.uk
India House, 45 Curlew Street
Event Organisers
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release NICOX discusses New Glaucoma Treatment at SMi’s 3rd Ophthalmic Drugs Conference here
News-ID: 1822357 • Views: …
More Releases from SMi Group Ltd
Co-chairs invitation to attend the Pharmaceutical Cleanrooms Conference in Londo …
SAE Media Group reports: Conference co-chairs invite you to attend the 2nd Annual Next Generation Pharmaceutical Cleanrooms this October 2022.
The conference will be co-chaired by Conor Murray, Chairman, Irish Cleanroom Society and Connor McMorrow, Aseptic Lead Cell Therapy, Takeda, in which they have released an invitation letter for all interested parties.
Excerpt of the Co-Chair invitation letter:
'As joint chairs of the 2nd Annual Next Generation Pharmaceutical Cleanrooms Conference, it is our…
Exclusive Speaker Interview with Karen Capper, AstraZeneca ahead of the Pharmace …
SMi Group reports: exclusive speaker interview with microbiology expert Karen Capper, AstraZeneca about the developments in the microbiology field.
Now in its 10th Annual year, the Pharmaceutical Microbiology UK conference is one not to be missed. Taking place on 17th and 18th January 2022 as a virtual conference with online access only.
The conference will bring together industry experts to discuss and analyse the latest advancements and challenges within pharmaceutical microbiology.
Interested…
SMi’s 3D Cell Culture conference 2022 – Speakers announced
SMi Reports: Agenda and speaker overview of the upcoming 5th Annual 3D Cell Culture Conference.
SMi Group is delighted to announce the return of the successful 3D Cell Culture Conference for its 5th year, taking place on 9th and 10th February 2022 in London, UK. Over the past few years, 3D Cell Culture has gained momentum within the pharmaceutical industry due to the benefits that this model offers for in…
Maritime Safety Briefings to Look Forward to at Defence Safety 2020
Defence Safety 2020 will provide a comprehensive overview of safety within the military, aiming to review the safe delivery of defence capabilities, and the parts that operational users, equipment, and service delivery organisations, as well as research and development play.
Once again supported by the UK MoD Defence Safety Authority, the event will feature a diverse, international speaker line-up of military and industry experts, who will explore the latest updates on…
More Releases for NICOX
Cetirizine Hydrochloride Market Generated Opportunities, Future Scope 2025-2032 …
Latest Report, titled "Cetirizine Hydrochloride Market" Trends, Share, Size, Growth, Opportunity and Forecast 2025-2032, by Coherent Market Insights offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The report features a comprehensive table of contents, figures, tables, and charts, as well as insightful analysis. The Cetirizine Hydrochloride market has been expanding significantly…
Bacterial Conjunctivitis Market to Witness Growth by 2032 | Allergan, Alembic Ph …
DelveInsight's "Bacterial Conjunctivitis Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Bacterial Conjunctivitis, historical and forecasted epidemiology as well as the Bacterial Conjunctivitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
The Bacterial Conjunctivitis market report provides current treatment practices, emerging drugs, the market share of individual therapies, and the current and forecasted Bacterial Conjunctivitis market size from…
Viral Conjunctivitis Pipeline Drugs Market May Set Epic Growth Story | Novartis …
Advance Market Analytics published a new research publication on "Viral Conjunctivitis Pipeline Drugs Market Insights, to 2028" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Viral Conjunctivitis Pipeline Drugs market was mainly driven by the increasing R&D spending across the world.
Some of the…
Sjögren’s Syndrome Market Segment Analysis By Eisai Co., Ltd.,., Novartis AG, …
Sjögren’s Syndrome Market is rising gradually with a steady CAGR of 4% in the forecast period of 2020-2027. The report contains data of the base year 2019 and historic year 2018. Increasing incidence of Sjogren’s syndrome and presence of a strong pipeline for the disease is contributing towards this market growth in the upcoming years.
Global Sjögren’s Syndrome Market By Type (Primary Sjögren’s Syndrome, Secondary Sjögren’s Syndrome), Symptoms (Dry Eyes, Dry Mouth, Others),…
CONJUNCTIVITIS TREATMENT MARKET SIZE TO 2026: NICOX, EYEVANCE PHARMACEUTICALS LL …
Global Conjunctivitis Treatment Market is rising gradually with a substantial CAGR in the forecast period of 2019-2026. Growing population of stye population worldwide and emergence of drugs used in the treatment of risk associated with stye disease are the key factors to drive the market growth. Global Conjunctivitis Treatment Market By Type (Allergic Conjunctivitis, Infectious Conjunctivitis, Chemical Conjunctivitis), Therapy Type (Antibiotic Therapy and Eye Warming Therapy), Drugs (Antibiotics, Ophthalmic Steroids, Non-Steroidal Anti-Inflammatory…
Global Artificial Tears Market Analysis by Top Manufacturers: Johnson & Johnson, …
Qyresearchreports include new market research report Global Artificial Tears Market Research Report 2018 to its huge collection of research reports.
In this report, the global Artificial Tears market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue…
